Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets

Vital Signs - Next-Generation Sequencing Services Market: An Expanding Role in Clinical Applications Opens New Markets

 

RELEASE DATE
30-Mar-2012
REGION
North America
Deliverable Type
Market Research
Research Code: 9561-00-DB-00-00
SKU: HC00645-NA-MR_04118
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00645-NA-MR_04118
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market.

Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.

Table of Contents

This week's issue

This issue of Vital Signs, released on March 30, 2012, provides a strategic insight on the next-generation sequencing services market. Additionally, a company spotlight is provided for Foundation Medicine. Founded in 2010, the cancer diagnostics firm aims to transform cancer care by including comprehensive molecular analysis of tumors from next-generation sequencing to the diagnostic process. Reimbursement and regulatory news from the FDA is also provided for week of March 12, 2012.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-DB-00-00
Is Prebook No